Study to Evaluate the Effects of Itraconazole and Rifampin on the Pharmacokinetics of ASC40 in Healthy Subjects
Clinical trial NCT04843449 · COMPLETED
Trial details
- NCT number
- NCT04843449
- Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-04
- Primary completion
- 2021-05-06
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.